# abciximab

> glycoprotein IIb/IIIa receptor antagonist, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures

**Wikidata**: [Q307088](https://www.wikidata.org/wiki/Q307088)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Abciximab)  
**Source**: https://4ort.xyz/entity/abciximab


## References

1. Abciximab. DrugBank. 2015
2. AC1MXG0L. PubChem
3. Abciximab. ChEMBL
4. Freebase Data Dumps. 2013
5. 1-[(4-Chloro-2,5-dimethylphenyl)sulfonyl]-4-{1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-1H-imidazol-2-yl}piperidine. ChemSpider
6. A reference set of clinically relevant adverse drug-drug interactions
7. Abciximab. Hazardous Substances Data Bank. 2019
8. ABCIXIMAB. NDF-RT
9. NDF-RT
10. Drug Indications Extracted from FAERS
11. Medical Subject Headings
12. [Source](https://www.whocc.no/atc_ddd_index/?code=B01AC13)
13. [OpenAlex](https://docs.openalex.org/download-snapshot/snapshot-data-format)
14. UniChem